anti-cancer peptides anti - List of anticancerpeptides exhibits antitumor activity Unlocking the Potential of Anti-Cancer Peptides in Modern Therapeutics

List of anticancerpeptides Anti-cancer peptides (ACPs) are emerging as a significant area of research and development in the fight against cancer. These molecules, often described as a series of short peptides composed of 10–60 amino acids, offer a novel therapeutic approach with unique advantages over traditional treatments. Their ability to directly target cancer cells, modulate the immune system, and overcome treatment resistance makes them a promising frontier in oncology作者：AR Collins·2025·被引用次数：1—Cancer vaccines are based onanticancer peptidesthat are 20–30 amino acids that contain specific epitopes for antigens known to be highly ....

The scientific community is actively exploring the diverse mechanisms through which anti-cancer peptides exert their effects.作者：M Karami Fath·2022·被引用次数：143—Antimicrobial peptides arenew anticancer medications made by eukaryotic and prokaryotic organismsthat can kill cancer cells. These peptides ... Research indicates that these peptides can act on tumor cells to exert their anti-cancer effect through various pathways, including the inhibition of tumor cell proliferation and migration. Some anticancer peptides are known to be cationic amphipathic peptides that bind to and kill cancer cells either by a direct- or indirect-acting mechanism. This direct action can involve disrupting cancer cell membranes or inducing apoptosis (programmed cell death). Beyond direct cytotoxicity, many anti-cancer peptides demonstrate potent immunomodulatory activity, effectively influencing the body's immune response to fight cancer. For instance, these peptides can inhibit pro-inflammatory responses that often aid cancer progression, thereby enhancing the body's natural defenses against malignant cellsGHK-Cu Peptide | The benefits, side effects, and more [2026].

The development of peptide-based anticancer therapeutics is rapidly advancing, with a growing number of these agents showing significant promisePeptides: What are they, uses, and side effects. Databases like CancerPPD-2.0 are crucial for cataloging and analyzing these peptides, providing valuable information on their sequences, lengths, experimental techniques, and structures.GHK-Cu Peptide | The benefits, side effects, and more [2026] This curated data helps researchers identify and characterize new anti-cancer bioactive peptides (ACPs). Furthermore, protein/peptide drugs possess unique advantages such as high pharmacological potency, molecular specificity, multifunctionality, and low toxicity, making them attractive alternatives to conventional chemotherapy. Compared to traditional chemotherapy drugs, anti-cancer peptides have many unique advantages, including excellent biocompatibility and efficient therapeutic efficacy with a lower risk of side effects.

The versatility of anti-cancer peptides is further highlighted by their ability to target various hallmarks of tumors. They are being investigated for their capacity to combat sustained proliferative signaling, overcome resistance to apoptosis, and address metabolic reprogramming within cancer cells. Their effectiveness is not limited to specific cancer types; for example, research has shown that certain peptides at a concentration of 0.05 µM can significantly inhibit prostate cancer cells and prevent their migration *in vitro*.

The exploration of anti-cancer peptides extends to both natural and synthetic sources. For instance, the peptide lycosin-1, derived from spider venom, has demonstrated an ability to hinder the growth of cancer cells and reduce tumor size in laboratory settingsGHK-Cu Peptide | The benefits, side effects, and more [2026]. Additionally, new anticancer medications made by eukaryotic and prokaryotic organisms are being developed, leveraging the inherent bioactivity of these natural compounds. The potential use of peptides as anticancer drugs is a subject of ongoing review, with current research highlighting both the existing landscape and future prospects in this field.作者：M Karami Fath·2022·被引用次数：143—Antimicrobial peptides arenew anticancer medications made by eukaryotic and prokaryotic organismsthat can kill cancer cells. These peptides ...

Beyond direct cancer cell killing, anti-cancer peptides are being engineered to act as targeted therapeutic agents that can specifically bind to and target cancer cells or cancer-related molecules. This targeted approach minimizes damage to healthy tissues, a common challenge with conventional therapies作者：R Ghavimi·2025·被引用次数：7—The peptides at a concentration of 0.05 μMsignificantly inhibit prostate cancer cellsand can prevent cancer cells from migrating in vitro(46). H-10 is a .... Furthermore, peptides' ability in crossing the cell membrane to reach intracellular targets is a critical factor for developing effective anticancer agents, allowing them to access intracellular signaling pathways and molecular machinery crucial for cancer cell survival and proliferation.作者：X Chen·2024·被引用次数：10—Anticancer peptides target various hallmarks of tumors, including combating sustained proliferative signaling, resistance to apoptosis, metabolic reprogramming, ...

The field of peptide research is not limited to direct anti-cancer activity.Anticancer Activities of Natural and Synthetic Peptides Some peptides are known for their broader health benefits, such as anti-inflammatory properties, which can be relevant in managing the side effects of cancer treatment or supporting overall well-being作者：M Xie·2020·被引用次数：288—Anti-cancer peptides (ACPs) area series of short peptides composed of 10–60 amino acidsthat can inhibit tumour cell proliferation or migration.. While some copper peptide complexes are marketed for cosmetic and wound-healing benefits, their direct role in cancer therapy is still under investigation, and currently, there is not enough evidence to recommend taking them specifically for cancer treatment. Similarly, while research is exploring the relationship between collagen and cancer, definitive recommendations for collagen supplementation in cancer management are not yet established.

The future of anti-cancer peptides appears bright, with ongoing advancements in their design, delivery, and application.2025年5月2日—Peptidesare smaller versions of proteins. They may provide pro-aging support,anti-inflammatory, or muscle-building properties. Researchers are focused on developing different anti-cancer peptides with enhanced potency, specificity, and reduced toxicity. The development of peptide drugs: a new direction in cancer immunotherapy is particularly exciting, as these agents can synergize with the immune system for a more robust anti-cancer response. As research progresses, anti-cancer peptides are poised to become an indispensable part of the modern therapeutic arsenal against cancer.